Skip to content

13F-HR filed by Sio Capital Management, LLC

Sio Capital Management, LLC filed this 13F-HR for the quarter ended 2020-06-30, filed 2020-08-14, with 78 holding rows worth $342,675,000.

Accession
0001214659-20-007110
Filed
2020-08-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2020

A holdings report, 78 entries on the cover page, a total value of $342,675,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $342,675,000 with VALUE read as thousands by filing date, 13F file number 028-13691. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
COHERUS ONCOLOGY INC19249H103COM1,135,863$20,287,000thousands by filing date
SPDR GOLD TR78463V107GOLD SHS120,702$20,202,000thousands by filing date
MCKESSON CORP COM58155Q103Stock97,285$14,925,000thousands by filing date
TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS881624209ADR962,796$11,871,000thousands by filing date
GW PHARMACEUTICALS PLC36197T103ADS94,984$11,656,000thousands by filing date
CENCORA INC COM03073E105Stock100,545$10,132,000thousands by filing date
MOLINA HEALTHCARE INC60855R100COM56,807$10,111,000thousands by filing date
HILL ROM HLDGS INC431475102COM90,000$9,880,000thousands by filing date
Merck & Co.,Inc.58933Y105COM114,350$8,843,000thousands by filing date
Mersana Therapeutics Inc59045L106Common Stock371,781$8,700,000thousands by filing date
R1 RCM INC749397105COM763,023$8,508,000thousands by filing date
Elevance Health, Inc.036752103COM31,819$8,368,000thousands by filing date
CYMABAY THERAPEUTICS INC23257D103COM2,299,982$8,027,000thousands by filing date
SOLITON INC834251100COM1,025,000$7,975,000thousands by filing date
HCA Healthcare Inc40412C101COM81,732$7,933,000thousands by filing date
UNITED THERAPEUTICS CORP DEL COM91307C102Stock65,210$7,890,000thousands by filing date
Eli Lilly and Company532457108COM45,901$7,536,000thousands by filing date
MESOBLAST LTD F SPONSORED ADR 1 ADR REPS 10 ORD SHS590717104SPONS ADR641,200$7,303,000thousands by filing dateput
CARDINAL HEALTH INC14149Y108COM133,500$6,967,000thousands by filing date
BRISTOL-MYERS SQUIBB CO110122157RIGHT 99/99/99991,719,271$6,155,000thousands by filing date
ORTHOFIX MED INC68752M108COM191,891$6,141,000thousands by filing date
ARENA PHARMACEUTICALS INC040047607COM NEW95,153$5,990,000thousands by filing date
ORASURE TECHNOLOGIES INC68554V108COM460,000$5,350,000thousands by filing date
WALGREENS BOOTS ALLIANCE INC931427108COM124,194$5,265,000thousands by filing date
CURIS INC231269200COM4,300,051$5,203,000thousands by filing date
VIKING THERAPEUTICS INC92686J106COM709,780$5,118,000thousands by filing date
RADIUS HEALTH INC750469207COM NEW362,402$4,940,000thousands by filing date
CEL-SCI CORP150837607COM PAR NEW330,900$4,937,000thousands by filing dateput
AFFIMED N VN01045108COM933,150$4,306,000thousands by filing date
CHARDAN HEALTHCR ACQSTN 2 CO15957T206UNIT 99/99/9999400,000$4,200,000thousands by filing date
ARDELYX INC039697107COM601,534$4,163,000thousands by filing date
LARIMAR THERAPEUTICS INC517125100COM318,258$4,090,000thousands by filing date
QUANTERIX CORP74766Q101COMMON STOCK145,907$3,996,000thousands by filing date
Boston Scientific Corporation101137107COM112,036$3,934,000thousands by filing date
IMMUNOVANT INC45258J102COM152,450$3,712,000thousands by filing date
BIOGEN INC COM09062X103Stock13,800$3,692,000thousands by filing date
BIOGEN INC COM09062X103Stock13,800$3,692,000thousands by filing dateput
NOVABRIDGE BIOSCIENCES44975P103CMN118,409$3,544,000thousands by filing date
ESPERION THERAPEUTICS INC NEW COM29664W105Stock61,600$3,161,000thousands by filing date
LEAP THERAPEUTICS INC52187K101COM1,501,998$3,139,000thousands by filing date
VAPOTHERM INC922107107COM75,953$3,113,000thousands by filing date
SYROS PHARMACEUTICALS INC87184Q107COM272,902$2,909,000thousands by filing date
Viewra, Inc92672L107COM1,294,790$2,900,000thousands by filing date
ACTINIUM PHARMACEUTICALS INC00507W107COM8,147,650$2,864,000thousands by filing date
ASLAN PHARMACEUTICALS LTD04522R101ADR1,376,954$2,754,000thousands by filing date
CERECOR INC15671L109COM1,000,000$2,600,000thousands by filing date
LIFESCI ACQUISITION CORP53228P208UNIT 03/31/2025210,000$2,310,000thousands by filing date
RADNET INC750491102COM135,254$2,146,000thousands by filing date
ZYNERBA PHARMACEUTICALS INC98986X109COM629,000$2,120,000thousands by filing dateput
AEGLEA BIOTHERAPEUTICS INC00773J103COM211,104$1,953,000thousands by filing date
INOGEN INC45780L104COM54,000$1,918,000thousands by filing date
DYADIC INTL INC DEL26745T101COM209,064$1,810,000thousands by filing date
VANDA PHARMACEUTICALS INC921659108COM144,114$1,649,000thousands by filing date
Ohr Pharmaceutical Inc64132K102COM179,404$1,575,000thousands by filing date
PRECISION BIOSCIENCES INC74019P108COM185,053$1,541,000thousands by filing date
ANIKA THERAPEUTICS INC035255108COM36,032$1,359,000thousands by filing date
HARROW INC415858109COM238,623$1,243,000thousands by filing date
MORPHIC HLDG INC61775R105COM45,386$1,228,000thousands by filing date
CATALYST BIOSCIENCES INC14888D208COM198,714$1,166,000thousands by filing date
AYALA PHARMACEUTICALS INC05465V108COM114,546$1,157,000thousands by filing date
SUTRO BIOPHARMA INC869367102COM148,400$1,152,000thousands by filing date
KODIAK SCIENCES INC50015M109COM20,595$1,115,000thousands by filing date
PROGYNY INC COM74340E103Stock39,310$1,015,000thousands by filing date
MINERVA NEUROSCIENCES INC COM NEW603380106Stock243,300$878,000thousands by filing dateput
Aravive Inc03890D108Common / Ordinary Stock68,373$796,000thousands by filing date
BIONANO GENOMICS INC09075F107COM1,546,184$789,000thousands by filing date
IDEAYA BIOSCIENCES INC COM45166A102Stock55,000$782,000thousands by filing date
TRILLIUM THERAPEUTICS INC COM NEW89620X506Stock86,757$702,000thousands by filing date
KURA ONCOLOGY INC COM50127T109Stock42,683$696,000thousands by filing date
NEOLEUKIN THERAPEUTICS INC64049K104COM38,312$636,000thousands by filing date
ATRECA INC04965G109COM21,523$458,000thousands by filing date
RAPT THERAPEUTICS INC75382E109COM14,298$415,000thousands by filing date
KADMON HLDGS INC48283N106COM52,500$269,000thousands by filing date
SERES THERAPEUTICS INC81750R102COM55,500$264,000thousands by filing dateput
CELLECTAR BIOSCIENCES INC15117F500COM PAR189,457$243,000thousands by filing date
MEI PHARMA INC55279B202COM NEW48,047$198,000thousands by filing date
BELLICUM PHARMACEUTICALS INC COM NEW079481404Stock7,751$58,000thousands by filing date
FUSION PHARMACEUTICALS INC36118A100COM3,000$52,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001214659-20-007110this filing2020-08-14acceptance time not in the bulk data set